NL-OMON46424Not yet recruitingNot Applicable
Exploring characteristics of haemodialysis patients related to successful individual application of bioimpedance to help determine the endpoint of dialysis treatment - Biolyse
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Wageningen Universiteit
- Enrollment
- 120
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 64 (—)
Inclusion Criteria
- •ESRD patients undergoing intermittent daytime haemodialysis treatment at Ziekenhuis Gelderse Vallei in Ede
- •Undergoing routine HD treatment for at least three months
Exclusion Criteria
- •Metal implants
- •Major amputations
- •Restless legs
Investigators
Similar Trials
Completed
Phase 4
The effects of irbesartan and nebivolol on ambulatory blood pressure in patients with intradialytic hypertension.Patients with end-stage renal disease on hemodialysis with intradialytic hypertensionUrological and Genital DiseasesEnd-stage renal diseaseISRCTN13587185Aristotle University of Thessaloniki School of Medicine38
Not yet recruiting
Phase 2
A study to gain indepth understanding of Quality of Life of patients undergoing Hemodialysis and assess the effect of Family Empowerment program (Hemodialysis guide and Counseling) on Quality of Life, Adherence, Clinical Outcome and Care giver BurdeCTRI/2022/04/041933PARAMESWARI M
Completed
Not Applicable
Evaluating the relationship between haemodialysis and glucose control in insulin-treated diabetic patients - a pilot studydiabetes mellitusNL-OMON39344niversitair Medisch Centrum Groningen20
Active, not recruiting
Not Applicable
Manchester vascular access studyTopic: Renal disordersSubtopic: Renal disordersDisease: All Renal disordersUrological and Genital DiseasesISRCTN57422410Central Manchester & Manchester Childrens University Hospital NHS Trust (UK)250
Completed
Unknown
Characteristics of Dialysis Patients who Developed Non-Occlusive Mesenteric Ischemiaon-Occlusive Mesenteric IschemiaJPRN-UMIN000050191Tokyo Bay Urayasu Ichikawa Medical Center19